Molnupiravir
In stock
200mg
from A$344.87
In brief
In Australia, Lagevrio (molnupiravir) has provisional approval to treat COVID-19 in adults at increased risk of hospitalisation or death.
What is molnupiravir used for?
According to the Lagevrio consumer medicine information, Lagevrio has provisional approval in Australia to treat COVID-19 in adults who are at increased risk of hospitalisation or death.
This listing shows molnupiravir 200 mg, sold by the bottle. It does not name the manufacturer of the capsules supplied, so check the label on the pack you receive and confirm with your prescriber or pharmacist that it matches your prescription.
Molnupiravir, Lagevrio and Molnunat
Molnupiravir is the active ingredient. Lagevrio is the brand sponsored in Australia by Merck Sharp & Dohme, supplied as 200 mg capsules. Molnunat is the name used in our supplier’s listing for this product.
When is molnupiravir started?
According to the Lagevrio product information, it is started as soon as possible after COVID-19 is diagnosed and within 5 days of the first symptoms, in adults at risk of severe illness. Safety and effectiveness beyond 5 days of treatment have not been established. The Lagevrio consumer information says it can be taken with or without food.
The delivery times shown in the “Delivery across Australia” section below can exceed the 5-day window after symptoms begin.
Lagevrio: allergies, age and pregnancy
- Allergy: not for anyone allergic to molnupiravir or any ingredient in the capsules
- Under 18: Lagevrio is not approved for people under 18
- Pregnancy: not recommended; a pregnancy test is advised before starting
It also does not recommend breastfeeding during treatment and for 4 days after the last dose.
Contraception during and after treatment
According to the Lagevrio consumer information, women should use effective contraception during treatment and for 4 days after the last dose, and men should use reliable contraception during treatment and for 3 months after the last dose.
Molnupiravir side effects
The Lagevrio consumer information lists diarrhoea, nausea, vomiting, dizziness and itching as common side effects.
It lists signs of an allergic reaction, such as hives, difficulty breathing or swallowing, swelling of the face, throat tightness or rash, as serious.
Storage
The Lagevrio consumer information advises storing the capsules in the original bottle in a cool, dry place below 30 °C, away from heat and sunlight. Follow the storage directions on the pack you receive.
Molnupiravir price: compare pack sizes
Prices are per number of bottles of molnupiravir 200 mg and are calculated from the listed prices at the shop’s Australian-dollar rate on 7 October 2026, before delivery or other checkout charges.
| Strength | Bottles | Pack price | Price per bottle |
|---|---|---|---|
| 200 mg | 1 | A$346.67 | A$346.67 |
| 200 mg | 2 | A$644.66 | A$322.33 |
| 200 mg | 3 | A$881.03 | A$293.68 |
| 200 mg | 4 | A$1,065.84 | A$266.46 |
Per bottle, two bottles cost about 7.0% less than one, three bottles about 15.3% less and four bottles about 23.1% less.
A lower price per bottle means a larger upfront payment. Choose only the quantity and strength appropriate to your prescription, and check the expiry date. Prices can change, so confirm the current pack price before ordering.
Frequently asked questions
Is molnupiravir the same as Lagevrio?
Lagevrio is a brand of molnupiravir.
Can molnupiravir be taken during pregnancy?
The Lagevrio consumer information does not recommend it in pregnancy.
How long is a course of molnupiravir?
The Lagevrio information describes a 5-day course; safety and effectiveness beyond 5 days have not been established.
Delivery across Australia
Airmail service: delivery in 14–22 days, free on orders over A$286.52. Trackable service: delivery in 7–14 days, with the tracking number sent by email. These are estimated delivery times, not guaranteed arrival dates.
Australian cities and delivery information
The Australian delivery options above apply to the destinations below. A city listing does not indicate a physical pharmacy branch or local stock.
| City | State or territory |
|---|---|
| Sydney | New South Wales |
| Melbourne | Victoria |
| Brisbane | Queensland |
| Perth | Western Australia |
| Adelaide | South Australia |
| Hobart | Tasmania |
| Gold Coast | Queensland |
| Canberra | Australian Capital Territory |
| Cairns | Queensland |
| Central Coast | New South Wales |
| Townsville | Queensland |
| Darwin | Northern Territory |
| Newcastle | New South Wales |
| Geelong | Victoria |
| Gladstone | Queensland |
| Port Macquarie | New South Wales |
| Bathurst | New South Wales |
| Forbes | New South Wales |
| Geraldton | Western Australia |
| Goulburn | New South Wales |
